WMT
Operator of a drug discovery company intended to develop selective translational inhibition therapies for cancer and inflammatory diseases operating in the pharmaceutical research domain. The company ...
Valuation
$0
Share Price
N/A
Total Raised
$10.9M
Last Round
N/A